Literature DB >> 20647829

Patient-selected treatment partners did not protect against drug resistance during first-line NNRTI-based HAART in a randomized trial.

Babafemi O Taiwo, John A Idoko, Anne-Geneviève Marcelin, Ihedinachi Otoh, Susheel Reddy, Paul G Iyaji, Oche Agbaji, Sudhir Penugonda, Patricia A Agaba, Robert L Murphy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20647829     DOI： 10.1097/QAI.0b013e3181e5112f

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN： 1525-4135            Impact factor:   3.731


× No keyword cloud information.
  3 in total

1.  How treatment partners help: social analysis of an African adherence support intervention.

Authors:  Kelli N O'Laughlin; Monique A Wyatt; Sylvia Kaaya; David R Bangsberg; Norma C Ware
Journal:  AIDS Behav       Date:  2012-07

2.  Study design and participant characteristics of a randomized controlled trial of directly administered antiretroviral therapy in opioid treatment programs.

Authors:  Bernadette Anna Mullen; Katie Cook; Richard D Moore; Cynthia Rand; Noya Galai; Mary E McCaul; Sheldon Glass; Krisann K Oursler; Gregory M Lucas
Journal:  BMC Infect Dis       Date:  2011-02-15       Impact factor: 3.090

3.  Immuno-virologic outcomes and immuno-virologic discordance among adults alive and on anti-retroviral therapy at 12 months in Nigeria.

Authors:  Chuka J Anude; Emeka Eze; Henry C Onyegbutulem; Man Charurat; Mary-Ann Etiebet; Samuel Ajayi; Patrick Dakum; Oluyemisi Akinwande; Chris Beyrer; Alash'le Abimiku; William Blattner
Journal:  BMC Infect Dis       Date:  2013-03-01       Impact factor: 3.090
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.